OverviewSuggest Edit
Moderna is pioneering messenger RNA therapeutics™, an entirely new in vivo drug modality that produces human proteins or antibodies inside patient cells, which are in turn active intracellularly or secreted. This breakthrough platform addresses currently undruggable targets, and offers an alternative to existing drug modalities for a wide range of disease conditions.
| Type | Public | |
| HQ | Cambridge, US | Map |
| Website | modernatx.com | |
| Employee Ratings | More |
Recent NewsAll News
- Moderna would never release coronavirus vaccine data different from 'reality,' chairman says
- Morgan Stanley now sees Moderna shares spiking 26% from current levels, cites 65% chance of success for virus vaccine (MRNA)
- Lonza CEO says on pace to make Moderna trial vaccine in June/July - CNBC
- Dow futures struggle for direction Tuesday evening after Moderna vaccine report sparks Dow's 390-point skid
Key People/Management at Moderna
Stephane Bancel
Chief Executive Officer, Director
Paul Sagan
Director
Stephen Hoge
President
Henri A. Termeer
Director
Tracey Franklin
Chief Human Resources Officer
Stephen Berenson
Director
Moderna Office Locations
Moderna has offices in Cambridge, Norwood, Chicago, Huntington and in 1 other location
Cambridge, US (HQ)
200 Technology Square
Cambridge, US
NE47, 500 Technology Square
Norwood, US
100 Upland Rd
Huddinge, SE
Hälsovägen 7-9
Moderna Financials and Metrics
Moderna Revenue
Moderna's revenue was reported to be $60.21 m in FY, 2019
| USD | |
|---|---|
Revenue (Q2, 2020) | 28.4m |
Market capitalization (14-Sept-2020) | 25.1b |
Closing stock price (14-Sept-2020) | 63.7 |
Cash (30-Jun-2020) | 1.8b |
EV | 23.5b |
Moderna's current market capitalization is $25.1 b.
Annual
Annual
Annual
Quarterly
| USD | Q3, 2017 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 |
|---|---|---|---|---|---|---|---|
Net Income | (243.3m) | (218.0m) | (132.7m) | (267.7m) | (390.9m) | (124.2m) | (240.9m) |
Depreciation and Amortization | 58.4m | 43.6m | 7.3m | 14.8m | 22.1m | 15.0m | |
Accounts Payable | 718.0k | (9.9m) | 1.7m | (1.5m) | (19.2m) | 2.3m | 11.5m |
Cash From Operating Activities | (239.8m) | (228.6m) | (143.9m) | (256.1m) | (363.2m) | (106.2m) | (130.1m) |
| USD | FY, 2016 |
|---|---|
Revenue/Employee | 302.9k |
Financial Leverage | -4.2 x |
Moderna Operating Metrics
Moderna's Clinical Programs was reported to be 10 in Q3, 2018.
Moderna Acquisitions / Subsidiaries
| Company Name | Date | Deal Size |
|---|---|---|
| Brizo | ||
| Moderna AB | ||
| Moderna Securities | ||
| ModernaTX |
Moderna Cybersecurity Score
Moderna Revenue Breakdown
Moderna revenue breakdown by business segment: 14.0% from Grant revenue, 14.6% from Collaboration revenue from affiliate and 71.4% from Collaboration revenue
Moderna Online and Social Media Presence
36.87k Twitter followers
Moderna has 36.87k Twitter Followers. The number of followers has increased 7.3% month over month and increased 121.8% quarter over quarter
Moderna's Trends
Twitter Engagement Stats for @moderna_tx
1k
Tweets
426
Following
36.9k
Followers
15
Tweets last 30 days
283.3
Avg. likes per Tweet
100%
Tweets with engagement
Moderna News and Updates
May 20, 2020
Moderna would never release coronavirus vaccine data different from 'reality,' chairman says
The company put out the extent of data it had available, Moderna Chairman Noubar Afeyan tells CNBC.
May 20, 2020
Morgan Stanley now sees Moderna shares spiking 26% from current levels, cites 65% chance of success for virus vaccine (MRNA)
Morgan Stanley raised its Moderna price target to $90 from $37, citing "initial promising Covid-19 vaccine data," according to a Wednesday note.
That's a 26% jump from where shares of Moderna currently trade.
The bank risk-adjusted its estimates following the early results of the vaccine and no…
May 20, 2020
Lonza CEO says on pace to make Moderna trial vaccine in June/July - CNBC
Contract drug manufacturer Lonza
still expects to supply drugmaker Moderna with
active ingredients for its experimental COVID-19 vaccine by June
or July to support laboratory trials, the Swiss company's
interim CEO, Albert Baehny, told CNBC on Wednesday.
May 19, 2020
Dow futures struggle for direction Tuesday evening after Moderna vaccine report sparks Dow's 390-point skid
U.S. stock-index futures ticked higher in thinly traded bumpy action Tuesday evening after the Dow snapped a three-session win streak in the last hour of the regular session, following a report that cast doubt on a coronavirus remedy. Futures for the Dow Jones Industrial Average rose 0.2% at 24,194…
May 19, 2020
Scientists Raise Questions About Moderna Vaccine In Market-Shaking Report
They have to publish a scientific paper, opting for issuing press releases instead.
May 19, 2020
Stocks making the biggest moves after hours: Urban Outfitters, Moderna, Johnson & Johnson and more
Check out the companies making headlines after the bell.
Moderna Blogs
February 26, 2020
Moderna Reports 2019 Fourth Quarter and Full Year Financial Results and Highlights Advancements in Core Modalities
Two of three dose cohorts in Phase 2 CMV vaccine (mRNA-1647) dose-confirmation study completed enrollment; third and final cohort rapidly enrolling Up to $2 billion to invest, including cash and investments, financing proceeds and potentially available grants; reiterates guidance that net cash used
February 24, 2020
Moderna Ships mRNA Vaccine Against Novel Coronavirus (mRNA-1273) for Phase 1 Study
mRNA-1273 delivered from Company’s cGMP facility in 42 days from sequence selection CAMBRIDGE, Mass. --(BUSINESS WIRE)--Feb. 24, 2020-- Moderna, Inc. , (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of
February 12, 2020
Moderna to Report Fourth Quarter and Full Year 2019 Financial Results on Wednesday, February 26th, 2020
Moderna to Report Fourth Quarter and Full Year 2019 Financial Results on Wednesday, February 26th, 2020
Content Import
Wed, 02/12/2020 - 16:30
Moderna to Report Fourth Quarter and Full Year 2019 Financial Results on Wednesday, February 26th, 2020
February 12, 2020 at 4:30 PM…
February 12, 2020
Moderna Announces Pricing of Public Offering of Shares of Common Stock
CAMBRIDGE, Mass. --(BUSINESS WIRE)--Feb. 11, 2020-- Moderna, Inc. (Nasdaq: MRNA), a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced the pricing of an underwritten
February 10, 2020
Moderna Announces Progress in Prophylactic Vaccines Modality with CMV Vaccine Phase 2 Study Data Now Expected in Third Quarter 2020 and Expands Investment in This Core Modality with Three New Development Candidates
Moderna Announces Progress in Prophylactic Vaccines Modality with CMV Vaccine Phase 2 Study Data Now Expected in Third Quarter 2020 and Expands Investment in This Core Modality with Three New Development Candidates
Content Import
Mon, 02/10/2020 - 17:11
Moderna Announces Progress in Prophy…
February 10, 2020
Moderna Announces First Patient Enrolled in Phase 1/2 Study of mRNA-3704 for Methylmalonic Acidemia
Moderna Announces First Patient Enrolled in Phase 1/2 Study of mRNA-3704 for Methylmalonic Acidemia
Content Import
Mon, 02/10/2020 - 17:10
Moderna Announces First Patient Enrolled in Phase 1/2 Study of mRNA-3704 for Methylmalonic Acidemia
February 10, 2020 at 5:10 PM EST
…
Moderna Frequently Asked Questions
Who are Moderna key executives?
Moderna's key executives are Stephane Bancel, Paul Sagan and Stephen Hoge.
How many employees does Moderna have?
Moderna has 830 employees.
What is Moderna revenue?
Latest Moderna annual revenue is $60.2 m.
What is Moderna revenue per employee?
Latest Moderna revenue per employee is $72.5 k.
Who are Moderna competitors?
Competitors of Moderna include Celyad, CureVac and Regulus Therapeutics.
Where is Moderna headquarters?
Moderna headquarters is located at 200 Technology Square, Cambridge.
Where are Moderna offices?
Moderna has offices in Cambridge, Norwood, Chicago, Huntington and in 1 other location.
How many offices does Moderna have?
Moderna has 6 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies